PRESS RELEASE |

Phreesia’s Danielle Lynch Named One of MM+M’s ‘Women to Watch’ for 2022

Phreesia is pleased to announce that the healthcare marketing industry trade MM+M has named Danielle Lynch, Vice President, Client Experience, to its Women to Watch class of 2022.

Now in its seventh year, the program recognizes successful leaders and up-and-coming talent in the industry who have inspired their colleagues, showcased new ways of doing business and taken healthcare marketing to new heights. Lynch was chosen as one of just 25 women to receive this year’s honors.

“I’m honored to be recognized by MM+M alongside such esteemed women leaders in the healthcare marketing field,” Lynch said. “I’m incredibly proud of the Phreesia Life Sciences team and the success we’ve achieved through hard work and collaboration.”

Since playing a pivotal role in taking Phreesia public in 2019, Lynch has doubled the size of her team and helped increase Life Sciences revenue by nearly 100%. She is admired by her colleagues for her innovation, tenacity, and her continued contributions to Phreesia’s mission of creating a better, more engaging healthcare experience.

“We are thrilled to see Danielle awarded this well-deserved honor,” David Linetsky, Phreesia’s Senior Vice President, Life Sciences, said. “Danielle built the Client Experience team—the engine behind Phreesia Life Sciences’ significant growth—from the ground up, and her vision and leadership have been instrumental to the team’s success.”

About Phreesia Life Sciences

Phreesia is the trusted leader in patient activation, giving providers, health plans, life sciences companies and other organizations tools to help patients take a more active role in their care. Founded in 2005, Phreesia enabled more than 120 million patient visits in 2022—more than 1 in 10 visits across the U.S.—scale that we believe allows us to make meaningful impact. Offering patient-driven digital solutions for intake, outreach, education and more, Phreesia enhances the patient experience, drives efficiency and improves healthcare outcomes. To learn more, visit phreesia.com.

Press contact:

Carly Helfand
chelfand@phreesia.com
332-910-6768